Screener
Sarepta Therapeutics, Inc. SRPT Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | As of June 30, 2026 | As of December 31, 2025 |
|---|---|---|
| Accounts receivable, net | 376,824 | 398,233 |
| Inventory | 904,273 | 914,744 |
| Manufacturing-related deposits and prepaids | 48,454 | 113,455 |
| Other current assets | 105,784 | 171,856 |
| Total current assets | 2,223,824 | 2,537,938 |
| Property and equipment, net | 325,991 | 345,125 |
| Right of use assets | 120,847 | 125,495 |
| Non-current inventory | 226,333 | 184,543 |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s prepaid & other current?
- Sarepta Therapeutics, Inc. (SRPT) reported prepaid & other current of $105.78M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s prepaid & other current changed year-over-year?
- Sarepta Therapeutics, Inc.'s prepaid & other current decreased by 17.1% year-over-year, from $127.59M to $105.78M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s prepaid & other current?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s prepaid & other current has grown at a -4.2% compound annual growth rate (CAGR), from $213.32M to $171.86M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Sarepta Therapeutics, Inc.'s prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude